An Update on Stem Cell Therapies for Acute Coronary Syndrome

Peter J. Psaltis, Daniel B. Spoon, Dennis T L Wong, Rajiv Gulati

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Well into the second decade since its conception, cell transplantation continues to undergo intensive evaluation for the treatment of myocardial infarction. At a mechanistic level, its objectives remain to replace lost cardiac cell mass with new functioning cardiomyocytes and vascular cells, thereby minimizing infarct size and scar formation, and improving clinical outcomes by preventing adverse left ventricular remodeling and recurrent ischemic events. Many different cell types, including pluripotent stem cells and various adult-derived progenitor cells, have been shown to have therapeutic potential in preclinical studies, while early phase human trial experience has provided divergent outcomes and fundamental lessons, emphasizing that there remain key issues to address and challenges to overcome before cell therapy can be applied to wider clinical practice. The purpose of this review is to provide a balanced update on recent seminal developments in this exciting field and look to the next important steps to ensure its forward progression.

Original languageEnglish (US)
JournalCurrent Cardiology Reports
Volume16
Issue number9
DOIs
StatePublished - Sep 1 2014

Fingerprint

Acute Coronary Syndrome
Cell- and Tissue-Based Therapy
Stem Cells
Pluripotent Stem Cells
Ventricular Remodeling
Cell Transplantation
Cardiac Myocytes
Cicatrix
Blood Vessels
Myocardial Infarction
Therapeutics

Keywords

  • Acute coronary syndrome
  • Angiogenesis
  • Bone marrow
  • Cell therapy
  • Embryonic stem cells
  • Endothelial progenitor cells
  • Induced pluripotent stem cells
  • Mesenchymal stem cells
  • Mononuclear cells
  • Myocardial infarction
  • Myocardial regeneration
  • Myocardial repair
  • Pluripotent stem cells
  • Stem cells
  • STEMI

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

An Update on Stem Cell Therapies for Acute Coronary Syndrome. / Psaltis, Peter J.; Spoon, Daniel B.; Wong, Dennis T L; Gulati, Rajiv.

In: Current Cardiology Reports, Vol. 16, No. 9, 01.09.2014.

Research output: Contribution to journalReview article

Psaltis, Peter J. ; Spoon, Daniel B. ; Wong, Dennis T L ; Gulati, Rajiv. / An Update on Stem Cell Therapies for Acute Coronary Syndrome. In: Current Cardiology Reports. 2014 ; Vol. 16, No. 9.
@article{ad16dd00bf1543c8a41fb2fc5d354cf9,
title = "An Update on Stem Cell Therapies for Acute Coronary Syndrome",
abstract = "Well into the second decade since its conception, cell transplantation continues to undergo intensive evaluation for the treatment of myocardial infarction. At a mechanistic level, its objectives remain to replace lost cardiac cell mass with new functioning cardiomyocytes and vascular cells, thereby minimizing infarct size and scar formation, and improving clinical outcomes by preventing adverse left ventricular remodeling and recurrent ischemic events. Many different cell types, including pluripotent stem cells and various adult-derived progenitor cells, have been shown to have therapeutic potential in preclinical studies, while early phase human trial experience has provided divergent outcomes and fundamental lessons, emphasizing that there remain key issues to address and challenges to overcome before cell therapy can be applied to wider clinical practice. The purpose of this review is to provide a balanced update on recent seminal developments in this exciting field and look to the next important steps to ensure its forward progression.",
keywords = "Acute coronary syndrome, Angiogenesis, Bone marrow, Cell therapy, Embryonic stem cells, Endothelial progenitor cells, Induced pluripotent stem cells, Mesenchymal stem cells, Mononuclear cells, Myocardial infarction, Myocardial regeneration, Myocardial repair, Pluripotent stem cells, Stem cells, STEMI",
author = "Psaltis, {Peter J.} and Spoon, {Daniel B.} and Wong, {Dennis T L} and Rajiv Gulati",
year = "2014",
month = "9",
day = "1",
doi = "10.1007/s11886-014-0526-z",
language = "English (US)",
volume = "16",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "9",

}

TY - JOUR

T1 - An Update on Stem Cell Therapies for Acute Coronary Syndrome

AU - Psaltis, Peter J.

AU - Spoon, Daniel B.

AU - Wong, Dennis T L

AU - Gulati, Rajiv

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Well into the second decade since its conception, cell transplantation continues to undergo intensive evaluation for the treatment of myocardial infarction. At a mechanistic level, its objectives remain to replace lost cardiac cell mass with new functioning cardiomyocytes and vascular cells, thereby minimizing infarct size and scar formation, and improving clinical outcomes by preventing adverse left ventricular remodeling and recurrent ischemic events. Many different cell types, including pluripotent stem cells and various adult-derived progenitor cells, have been shown to have therapeutic potential in preclinical studies, while early phase human trial experience has provided divergent outcomes and fundamental lessons, emphasizing that there remain key issues to address and challenges to overcome before cell therapy can be applied to wider clinical practice. The purpose of this review is to provide a balanced update on recent seminal developments in this exciting field and look to the next important steps to ensure its forward progression.

AB - Well into the second decade since its conception, cell transplantation continues to undergo intensive evaluation for the treatment of myocardial infarction. At a mechanistic level, its objectives remain to replace lost cardiac cell mass with new functioning cardiomyocytes and vascular cells, thereby minimizing infarct size and scar formation, and improving clinical outcomes by preventing adverse left ventricular remodeling and recurrent ischemic events. Many different cell types, including pluripotent stem cells and various adult-derived progenitor cells, have been shown to have therapeutic potential in preclinical studies, while early phase human trial experience has provided divergent outcomes and fundamental lessons, emphasizing that there remain key issues to address and challenges to overcome before cell therapy can be applied to wider clinical practice. The purpose of this review is to provide a balanced update on recent seminal developments in this exciting field and look to the next important steps to ensure its forward progression.

KW - Acute coronary syndrome

KW - Angiogenesis

KW - Bone marrow

KW - Cell therapy

KW - Embryonic stem cells

KW - Endothelial progenitor cells

KW - Induced pluripotent stem cells

KW - Mesenchymal stem cells

KW - Mononuclear cells

KW - Myocardial infarction

KW - Myocardial regeneration

KW - Myocardial repair

KW - Pluripotent stem cells

KW - Stem cells

KW - STEMI

UR - http://www.scopus.com/inward/record.url?scp=84926130452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926130452&partnerID=8YFLogxK

U2 - 10.1007/s11886-014-0526-z

DO - 10.1007/s11886-014-0526-z

M3 - Review article

C2 - 25073868

AN - SCOPUS:84926130452

VL - 16

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 9

ER -